penile disorder
penile disorder
Explore linked clinical trials. Standard reference: MONDO:000203673 results · Page 1 of 3
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, bladder adenocarcinoma, bladder clear cell adenocarcinoma, bladder mixed adenocarcinoma, bladder squamous cell carcinoma, bladder urachal adenocarcinoma, carcinoma, chromophobe renal cell carcinoma, epithelial neoplasm, infiltrating bladder urothelial carcinoma, kidney cancer, kidney disorder, kidney medullary carcinoma, large cell neuroendocrine carcinoma, male reproductive organ cancer, male reproductive system disorder, malignant testicular Leydig cell tumor, neoplasm, papillary renal cell carcinoma, penile disorder, penile neoplasm, prostate cancer, prostate disorder, renal cell carcinoma, sarcomatoid renal cell carcinoma, transitional cell carcinoma, urethra clear cell adenocarcinoma, urethra neoplasm, urethral disorder, urinary bladder disorder, urinary bladder neoplasm, urinary bladder small cell neuroendocrine carcinoma, urinary system disorder | Recruiting | Phase 2 | 2026-10-09 | NCT03866382 | |
| E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers | Anal Cancer, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Head and Neck Neoplasms, Male Urogenital Diseases, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, anus disorder, anus neoplasm, cervix disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, female reproductive system disorder, female reproductive system neoplasm, human papillomavirus-related penile squamous cell carcinoma, human papillomavirus-related squamous cell carcinoma, intestinal disorder, male reproductive organ cancer, male reproductive system disorder, neoplasm, otorhinolaryngologic disease, penile cancer, penile disorder, penile neoplasm, rectal disorder, rectal neoplasm, uterine disorder, vaginal cancer, vaginal disorder, vulva cancer, vulvar disease | Recruiting | Phase 1 / Phase 2 | 2026-10-06 | NCT05639972 | |
| Worldwide Yearly Screening for Hypospadias | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Urogenital Abnormalities, Urogenital Diseases, hypospadias, male reproductive system disorder, penile disorder | Recruiting | Not applicable | 2026-10-01 | NCT06966375 | |
| Linking In With Advice and Supports for Men Impacted by Metastatic Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, endocrine system disorder, gonadal disorder, kidney cancer, kidney disorder, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, neoplasm, penile cancer, penile disorder, penile neoplasm, prostate cancer, prostate disorder, testicular cancer, testicular disorder, urinary system disorder | Active, not recruiting | Not applicable | 2026-10-01 | NCT05946993 | |
| DEfeating PEnile CAncer-2 | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, penile cancer, penile disorder, penile neoplasm | Recruiting | Not applicable | 2026-09-30 | NCT07378670 | |
| Platelet-Rich Plasma for Peyronie's Disease | Genital Diseases, Male Urogenital Diseases, Peyronie disease, Skin and Connective Tissue Diseases, Urogenital Diseases, connective tissue disorder, male reproductive system disorder, penile disorder | Recruiting | Not applicable | 2026-09-22 | NCT07117955 | |
| A Study of Becotatug Vedotin Combined With Pucotenlimab in the Treatment of EGFR-Positive Advanced Penile Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, penile cancer, penile disorder, penile neoplasm | Recruiting | Phase 2 | 2026-09-18 | NCT07497919 | |
| Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, bladder squamous cell carcinoma, bladder transitional cell carcinoma, carcinoma, clear cell renal carcinoma, epithelial neoplasm, kidney cancer, kidney disorder, kidney medullary carcinoma, male reproductive organ cancer, male reproductive system disorder, neoplasm, penile carcinoma, penile disorder, penile neoplasm, renal cell carcinoma, renal pelvis urothelial carcinoma, sarcomatoid renal cell carcinoma, squamous cell carcinoma of penis, ureter cancer, ureter transitional cell carcinoma, ureteral disorder, urethra neoplasm, urethra transitional cell carcinoma, urethral disorder, urinary bladder disorder, urinary bladder neoplasm, urinary bladder small cell neuroendocrine carcinoma, urinary system disorder | Active, not recruiting | Phase 1 | 2026-09-10 | NCT02496208 | |
| Emerging Indications for Hyperbaric Oxygen Treatment | Arterial Occlusive Diseases, Axonotmesis, Bacterial Infections and Mycoses, CNS demyelinating autoimmune disease, Clostridium Enterocolitis, Clostridium difficile colitis, Clostridium infectious disease, Cold Injury, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Conjunctival Diseases, Craniocerebral Trauma, Crohn disease, Crohn ileitis, Digestive System Diseases, Digestive System Fistula, Ear Diseases, Embolism and Thrombosis, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Fistula, Genital Diseases, Ileal Diseases, Infections, Invasive Fungal Infections, Male Urogenital Diseases, Necrosis, Neurologic Manifestations, Nonarteritic Anterior Ischemic Optic Neuropathy, Nutritional and Metabolic Diseases, Optic Neuropathy, Ischemic, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Raynaud disease, Rectovaginal Fistula, Sensation Disorders, Signs and Symptoms, Skin Abnormalities, Skin Ulcer, Skin and Connective Tissue Diseases, Urogenital Abnormalities, Urogenital Diseases, Vaginal Fistula, Venous Thrombosis, anal fistula, autoimmune disease, autoimmune disorder of the nervous system, bacterial infectious disease, bone disorder, branch retinal artery occlusion, calcinosis, calciphylaxis, calcium metabolic disease, cardiovascular disorder, central retinal vein occlusion, colitis, colonic disorder, cranial nerve neuropathy, decubitus ulcer, demyelinating disease, digestive system disorder, enteritis, enterocolitis, epidermolysis bullosa, eye disorder, female reproductive system disorder, frostbite, fungal infectious disease, gastroenteritis, graft versus host disease, gram-positive bacterial infections, hearing disorder, hereditary disease, hereditary skin disorder, hypospadias, immune system disorder, inclusion body myositis, inflammatory bowel disease, injury, intestinal disorder, intestinal fistula, livedoid vasculopathy, male reproductive system disorder, malignant otitis externa, metabolic disease, multiple sclerosis, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, nervous system injury, neuromuscular disease, optic nerve disorder, osteonecrosis, otorhinolaryngologic disease, penile disorder, peripheral vascular disease, pouchitis, prosthesis-related infectious disease, pterygium, pyoderma, pyoderma gangrenosum, rectal disorder, retinal artery occlusion, retinal disorder, retinal vein occlusion, skin disorder, skin vascular disease, thrombotic disease, tinnitus, ulcerative colitis, vaginal disorder, vascular disorder, vesiculobullous skin disease | Not yet recruiting | Phase 4 | 2026-09-09 | NCT07240649 | |
| International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study) | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, penile disorder, penile neoplasm | Active, not recruiting | Phase 3 | 2026-08-31 | NCT02305654 | |
| Delayed Dose Collagenase Clostridium Histolyticum (CCH) Protocol for Men With Peyronie's Disease | Genital Diseases, Male Urogenital Diseases, Peyronie disease, Skin and Connective Tissue Diseases, Urogenital Diseases, connective tissue disorder, male reproductive system disorder, penile disorder | Active, not recruiting | Phase 4 | 2026-08-26 | NCT06649539 | |
| Investigation of Surgery, Collagenase, and Restorex for the Improvement of Peyronie's | Genital Diseases, Male Urogenital Diseases, Peyronie disease, Skin and Connective Tissue Diseases, Surgical Wound, Urogenital Diseases, connective tissue disorder, injury, male reproductive system disorder, penile disorder | Active, not recruiting | Phase 4 | 2026-08-26 | NCT04786106 | |
| Neoadjuvant Pucotenlimab and Becotatug Vedotin for Locally Advanced Penile Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, penile cancer, penile disorder, penile neoplasm | Not yet recruiting | Phase 2 | 2026-08-17 | NCT07767266 | |
| Efficacy of PRF in Hypospadias Repair | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Urogenital Abnormalities, Urogenital Diseases, hypospadias, male reproductive system disorder, penile disorder | Not yet recruiting | Not applicable | 2026-08-11 | NCT07757828 | |
| A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Genitourinary Cancer, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, bladder urachal adenocarcinoma, carcinoma, epithelial neoplasm, kidney cancer, kidney disorder, male reproductive organ cancer, male reproductive system disorder, neoplasm, penile disorder, penile neoplasm, renal cell carcinoma, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder | Recruiting | Not stated | 2026-08-10 | NCT04923178 | |
| Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, adenoma, breast disorder, breast neoplasm, cervix disorder, endocrine system disorder, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, lung disorder, lung neoplasm, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, malignant mesothelioma, mesothelial neoplasm, mesothelioma, neoplasm, ovarian cancer, ovarian disorder, penile disorder, penile neoplasm, pleural neoplasm, respiratory system disorder, respiratory tract neoplasm, skin disorder, triple-negative breast carcinoma, uterine disorder | Active, not recruiting | Phase 1 | 2026-07-31 | NCT04491942 | |
| EGFR-ADC (Becotatug Vedotin) Combined With PD-1 Inhibitor (Pucotenlimab) in Neoadjuvant Treatment of Advanced Penile Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, penile cancer, penile disorder, penile neoplasm | Recruiting | Phase 2 | 2026-07-29 | NCT07518979 | |
| Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Genitourinary Cancer, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, adrenal cortex disorder, adrenal cortex neoplasm, adrenal gland cancer, adrenal gland disorder, carcinoma, endocrine system disorder, epithelial neoplasm, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, neoplasm, penile cancer, penile disorder, penile neoplasm, small cell carcinoma | Active, not recruiting | Phase 2 | 2026-07-23 | NCT03333616 | |
| Genetics of Differences of Sex Development and Hypospadias | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Urogenital Abnormalities, Urogenital Diseases, disorder of sexual differentiation, endocrine system disorder, gonadal disorder, hypospadias, male reproductive system disorder, penile disorder | Enrolling by invitation | Not applicable | 2026-07-22 | NCT03102554 | |
| Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neoplasms, Unknown Primary, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Soft Tissue Neoplasms, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, adrenal cortex disorder, adrenal cortex neoplasm, adrenal gland cancer, adrenal gland disorder, benign urinary system neoplasm, carcinoma, cardiovascular disorder, endocrine system disorder, epithelial neoplasm, kidney cancer, kidney disorder, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, neoplasm, neuroendocrine neoplasm, paraganglioma, penile disorder, penile neoplasm, pheochromocytoma, primitive neuroectodermal tumor, renal cell carcinoma, small cell carcinoma, urinary system disorder, vascular disorder, vascular neoplasm | Active, not recruiting | Phase 2 | 2026-07-17 | NCT02721732 | |
| Comparative Outcomes of Subtunical Microdissection and Grafting Versus Classical Plaque Incision and Grafting in Complex Peyronie's Disease | Genital Diseases, Male Urogenital Diseases, Peyronie disease, Skin and Connective Tissue Diseases, Urogenital Diseases, connective tissue disorder, male reproductive system disorder, penile disorder | Recruiting | Not applicable | 2026-07-09 | NCT07470528 | |
| A Study of Avelumab in Penile Cancer Who Are Unfit for or Have Progressed After Platinum-Based Chemotherapy | Genital Diseases, Male Urogenital Diseases, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, metastatic malignant neoplasm, neoplasm, penile cancer, penile disorder, penile neoplasm | Active, not recruiting | Phase 2 | 2026-07-06 | NCT03391479 | |
| Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers | Adnexal Diseases, Carcinoma, Medullary, Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Head and Neck Neoplasms, Liver Neoplasms, Male Urogenital Diseases, Mouth Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Neoplasms, Ductal, Lobular, and Medullary, Neoplasms, Fibrous Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Pancreatic Carcinoma, Skin and Connective Tissue Diseases, Stomatognathic Diseases, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, adenocarcinoma, adrenal gland cancer, adrenal gland disorder, anal carcinoma, anus disorder, anus neoplasm, benign urinary system neoplasm, brain cancer, brain disorder, breast carcinoma, breast disorder, breast neoplasm, carcinoma, carcinoma of esophagus, central nervous system cancer, central nervous system disorder, cervical carcinoma, cervix disorder, cholangiocarcinoma, colonic disorder, colorectal neoplasm, connective tissue neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, epithelial neoplasm, esophageal disorder, female reproductive system disorder, female reproductive system neoplasm, gastric carcinoma, gastric neoplasm, gonadal disorder, head and neck carcinoma, hepatocellular carcinoma, intestinal disorder, liver disorder, lung carcinoma, lung disorder, lung neoplasm, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, medullary thyroid gland carcinoma, mouth disorder, neoplasm, nervous system disorder, neuroendocrine carcinoma, neuroendocrine neoplasm, ovarian cancer, ovarian carcinoma, ovarian disorder, pancreas disorder, pancreatic neoplasm, penile carcinoma, penile disorder, penile neoplasm, primary peritoneal carcinoma, primitive neuroectodermal tumor, prostate cancer, prostate carcinoma, prostate disorder, rectal disorder, rectal neoplasm, respiratory system disorder, respiratory tract neoplasm, salivary gland cancer, salivary gland carcinoma, salivary gland disorder, sarcoma, skin carcinoma, skin disorder, solitary fibrous tumor, stomach disorder, testicular cancer, testicular disorder, thymic carcinoma, thyroid gland carcinoma, thyroid gland disorder, thyroid tumor, transitional cell carcinoma, urinary bladder carcinoma, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder, urothelial carcinoma, uterine cancer, uterine disorder, vaginal cancer, vaginal carcinoma, vaginal disorder | Active, not recruiting | Phase 1 | 2026-07-02 | NCT07118176 | |
| Effect of Caudal Block on Urethrocutaneous Fistula After Distal Hypospadias Repair | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Urogenital Abnormalities, Urogenital Diseases, hypospadias, male reproductive system disorder, penile disorder | Recruiting | Not applicable | 2026-06-30 | NCT07675798 | |
| Improving Parental Support in Hypospadias Care | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Urogenital Abnormalities, Urogenital Diseases, hypospadias, male reproductive system disorder, penile disorder | Recruiting | Not applicable | 2026-06-30 | NCT06832280 |